Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_provenance.
- NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_assertion description "[To explore the characteristics of BCR-ABL kinase domain point mutations in Chinese chronic myeloid leukemia (CML) patients, a cohort of 127 patients with hematologic or cytogenetic resistance to imatinib are screened by direct sequencing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_provenance.
- NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_assertion evidence source_evidence_literature NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_provenance.
- NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_assertion SIO_000772 20697894 NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_provenance.
- NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_assertion wasDerivedFrom gad-20130706 NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_provenance.
- NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_assertion wasGeneratedBy ECO_0000203 NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_provenance.
- gad-20130706 importedOn "2013-07-06" NP83954.RAa6__wUR0Js69Ts-O9XEyOXi2dln8E8ZY-fBObApnZa4130_provenance.